Dare Bioscience
DARE
21 hedge funds and large institutions have $798K invested in Dare Bioscience in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
400% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 2
50% more funds holding
Funds holding: 14 → 21 (+7)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
10% more capital invested
Capital invested by funds: $725K → $798K (+$73.3K)
0.06% less ownership
Funds ownership: 0.37% → 0.32% (-0.06%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$59.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$43.2K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$23K |
| 4 |
FFS
Founders Financial Securities
Towson,
Maryland
|
+$22.4K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$18K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$62.6K |
| 2 |
Renaissance Technologies
New York
|
-$18.9K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1K |
DARE Hedge Fund Activity: Q1 2020 in Review
21 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q1 2020, worth a combined $798K — up 10% from $725K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new DARE positions and 2 closed out — a net gain of 8 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $59.5K. The largest seller was Geode Capital Management, cutting an estimated $62.6K.
- 21 institutional investors held Dare Bioscience (DARE) as of Q1 2020, up from 14 in Q4 2019.
- Funds reported $798K of Dare Bioscience stock for Q1 2020, up 10% quarter-over-quarter.
- 10 funds opened new Dare Bioscience positions in Q1 2020 and 2 closed out, a net change of +8 holders.
- The largest Dare Bioscience buyer in Q1 2020 was Vanguard Group, an estimated $59.5K added.
- The largest Dare Bioscience seller in Q1 2020 was Geode Capital Management, an estimated $62.6K sold.
Based on aggregated 13F filings for Q1 2020.